ArticleMedicine2016

Cost-Effectiveness of Eplerenone Compared to Usual Care in Patients With Chronic Heart Failure and NYHA Class II Symptoms, an Australian Perspective.

Zanfina Ademi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.